Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess retention in treatment after induction with
buprenorphine/naloxone (BNX) sublingual tablets compared with generic buprenorphine and after
stabilization with BNX sublingual tablets compared with BNX film. Secondary objectives
included assessment of treatment effects on opioid withdrawal symptoms, opioid cravings, and
safety.
Phase:
Phase 3
Details
Lead Sponsor:
Orexo AB
Collaborator:
Worldwide Clinical Trials
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone